Domenick A Prosdocimo Selected Research

Domenick A Prosdocimo Research Topics

2	Insulin Resistance 01/2021 - 01/2013
2	Atherosclerosis 06/2017 - 10/2013
2	Heart Failure 05/2016 - 02/2014
2	Abdominal Aortic Aneurysm 04/2016 - 01/2016
2	Inflammation (Inflammations) 04/2016 - 10/2013
1	Muscular Diseases (Myopathy) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Glucose Intolerance 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2018
1	Metabolic Diseases (Metabolic Disease) 12/2017
1	Atherosclerotic Plaque (Atheroma) 06/2017
1	Cardiomyopathies (Cardiomyopathy) 05/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2015
1	Muscular Atrophy (Muscle Atrophy) 12/2015
1	Obesity 01/2015
1	Cardiomegaly (Heart Hypertrophy) 02/2014
1	Vascular Diseases (Vascular Disease) 10/2013
1	Hyperphosphatemia 03/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2008
1	Ischemia 09/2008

4	LipidsIBA 01/2021 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 09/2008
3	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 02/2014 - 01/2013
2	GlucocorticoidsIBA 05/2018 - 12/2015
2	Amino Acids FDA Link 05/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 12/2015 - 10/2013
2	Insulin (Novolin)FDA Link 01/2013 - 09/2008
1	Triglycerides (Triacylglycerol)IBA 12/2017
1	Apolipoproteins E (ApoE)IBA 06/2017
1	Branched-Chain Amino AcidsIBA 05/2016
1	Keto AcidsIBA 05/2016
1	ElastinIBA 04/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 12/2015
1	Therapeutic UsesIBA 12/2015
1	Performance-Enhancing SubstancesIBA 12/2015
1	MyostatinIBA 01/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	diphosphoric acid (pyrophosphoric acid)IBA 03/2010
1	Cyclic AMP (AMP, Cyclic)IBA 03/2010
1	CarbohydratesIBA 09/2008
1	Nonesterified Fatty Acids (NEFA)IBA 09/2008